ArticleAmerican journal of epidemiology2019
Rethinking Antimicrobial Resistance Surveillance: A Role for Lot Quality Assurance Sampling.
Article in American journal of epidemiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Trial
- Mapping antimicrobial resistance interventions in ASEAN countries: a scoping review of implementation patterns, One Health integration, and evidence gaps.Tropical medicine and health · 2026Review
- Antimicrobial resistance prevalence inApplied and environmental microbiology · 2025Article
- Assessment of water, sanitation and hygiene services within nineteen Rohingya camps in Cox's Bazar, Bangladesh in 2022.BMC health services research · 2025Article
- The opportunities for and barriers to antimicrobial resistance surveillance by lot quality assurance sampling in livestock: Findings from interviews with stakeholders in Germany.One health (Amsterdam, Netherlands) · 2025Article
- Knowledge of Tuberculosis Prevention Across Eight Districts in Central Uganda: An Analysis of Lot Quality Assurance Sampling Survey Data.Risk management and healthcare policy · 2025Article
- Sampling for malaria molecular surveillance.Trends in parasitology · 2023Review
- Teleclinical Microbiology: An Innovative Approach to Providing Web-Enabled Diagnostic Laboratory Services in Syria.American journal of clinical pathology · 2022Article
- Point prevalence survey to assess antibiotic prescribing pattern among hospitalized patients in a county referral hospital in Kenya.Frontiers in antibiotics · 2022Article
- Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021Review
- Antimicrobial resistance among uropathogens in the Asia-Pacific region: a systematic review.JAC-antimicrobial resistance · 2021Review
- Filling the gaps in the global prevalence map of clinical antimicrobial resistance.Proceedings of the National Academy of Sciences of the United States of America · 2021Article
- Case-based surveillance of antimicrobial resistance with full susceptibility profiles.JAC-antimicrobial resistance · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Global surveillance of antimicrobial resistance (AMR) is a key component of the 68th World Health Assembly Global Action Plan on AMR. Laboratory-based surveillance is inherently biased and lacks local relevance due to aggregation of data. We assessed the feasibility, sensitivity, and affordability of a population-based AMR survey using lot quality assurance sampling (LQAS), which classifies a population as having a high or low prevalence of AMR based on a priori defined criteria. Three studies were carried out in Medan and Bandung, Indonesia, between April 2014 and June 2017. LQAS classifications for 15 antibiotics were compared with AMR estimates from a conventional population-based survey, with an assessment of the cost of a single LQAS classification using microcosting methodology, among patients suspected of urinary tract infection at 11 sites in Indonesia. The sensitivity of LQAS was above 98%. The approach detected local variation in the prevalence of AMR across sites. Time to reach LQAS results ranged from 47 to 138 days. The average cost of an LQAS classification in a single facility was US$466. The findings indicate that LQAS-based AMR survey is a feasible, sensitive, and affordable strategy for population-based AMR surveys, providing essential data to inform local empirical treatment guidelines and antimicrobial stewardship efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.